Response-adaptive randomization can assign a larger proportion of later participants to the treatment currently estimated to be better, improving outcomes for participants within the trial. Its allocation probabilities depend on earlier outcomes, which complicates statistical inference; delayed responses and calendar-time trends can also make adaptation ineffective or biased, and an allocation aimed at patient benefit need not maximize power.
Articles by others on the same topic
There are currently no matching articles.